Inventor
Jason Allan Wiles
Inventor
Madison, CT, US
Overview
Patents· 57 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
A61KPreparations for medical, dental or toiletry purposes21%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium17%
C07BGeneral methods of organic chemistry11%
Y02ATechnologies for adaptation to climate change3%
C07KPeptides2%
C07HSugars0%
PatentTitleYear
11,084,800Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders202111,053,253Macrocyclic compounds for treatment of medical disorders202111,001,600Disubstituted compounds for treatment of medical disorders202110,961,252Quinazoline and indole compounds to treat medical disorders202110,919,884Amide compounds for treatment of immune and inflammatory disorders202110,906,887Amino compounds for treatment of immune and inflammatory disorders202110,822,352Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders202010,807,952Compounds for treatment of immune inflammatory disorders202010,689,409Amino compounds for treatment of complement mediated disorders202010,660,876Amino compounds for treatment of medical disorders202010,662,175Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders202010,550,140Ether compounds for treatment of complement mediated disorders202010,464,956Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders201910,428,094Amide compounds for treatment of complement mediated disorders201910,428,095Compounds for treatment of complement mediated disorders201910,385,097Ether compounds for treatment of medical disorders201910,370,394Carbamate, ester, and ketone compounds for treatment of complement mediated disorders201910,301,336Phosphonate compounds for treatment of complement mediated disorders201910,287,301Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders201910,253,053Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders201910,189,869Amino compounds for treatment of complement mediated disorders201910,138,225Amide compounds for treatment of medical disorders201810,106,563Ether compounds for treatment of complement mediated disorders201810,100,072Phosphonate compounds for treatment of complement mediated disorders201810,092,584Compounds for the treatment of medical disorders201810,092,547Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infections201810,087,203Compounds for treatment of complement mediated disorders201810,081,645Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders201810,011,612Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders201810,005,802Amide compounds for treatment of complement mediated disorders201810,000,516Phosphonate compounds for treatment of medical disorders20189,833,440Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections20179,828,396Alkyne compounds for treatment of complement mediated disorders20179,796,741'Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders'20179,758,537'Compounds for treatment of complement mediated disorders'20179,732,104'Ether compounds for treatment of complement mediated disorders'20179,732,103'Carbamate, ester, and ketone compounds for treatment of complement mediated disorders'20179,695,205'Amide compounds for treatment of complement mediated disorders'20179,663,543'Phosphonate compounds for treatment of complement mediated disorders'20179,643,986'Factor D inhibitors useful for treating inflammatory disorders'20179,598,446'Amino compounds for treatment of complement mediated disorders'20179,592,222'Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections'20179,474,742'Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections'20169,468,629'Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections'20169,447,132'Highly active nucleoside derivative for the treatment of HCV'20169,273,082'Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections'20169,125,904'Biphenyl imidazoles and related compounds useful for treating HCV infections'20158,946,422'8-methoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones and related compounds as anti-infective agents'20158,835,456'NS5A inhibitors useful for treating HCV'20148,809,313'Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections'20148,173,636'Hydroxylthienoquinolones and related compounds as anti-infective agents'20128,138,346'Method for synthesis of 8-alkoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones'20128,114,888'Isothiazoloquinolones and related compounds as anti-infective agents'20128,044,204'8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents'20117,902,365'Method for synthesis of 8-alkoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones'20117,659,399'1-thia-2,4a-diaza-cyclopenta[b]napththalene-3,4-diones and related compounds as anti-infective agents'20107,199,128'8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2021Patents assigned to ACHILLION PHARMACEUTICALS INC (57)· patent assignee history
2007–2018Based in Hamden, CT, US· patent location history
2012–2015Patents assigned to WILES JASON ALLAN (7)· patent assignee history
2012–2015Patents assigned to DESHPANDE MILIND (6)· patent assignee history
2012–2015Patents assigned to WANG QIUPING (6)· patent assignee history
2012–2015Patents assigned to HASHIMOTO AKIHIRO (5)· patent assignee history
2014–2021Based in Madison, CT, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ACHILLION PHARMACEUTICALS INC | 57 | 2007–2021 |
| WILES JASON ALLANself | 7 | 2012–2015 |
| DESHPANDE MILIND | 6 | 2012–2015 |
| WANG QIUPING | 6 | 2012–2015 |
| HASHIMOTO AKIHIRO | 5 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Madison, CT, US | 41 | 2014–2021 |
| Hamden, CT, US | 16 | 2007–2018 |